HAVCR1 and pancreatic adenocarcinoma: We found that the promoter methylation level of HAVCR1 was significantly downregulated in Liver hepatocellular carcinoma and Pancreatic adenocarcinoma (Figures 2F,G), which might lead to HAVCR1 overexpression.